Fresh Tracks Therapeutics (NASDAQ:FRTX) Stock Price Down 0.5% – Should You Sell?

Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTXGet Free Report)’s stock price dropped 0.5% during trading on Wednesday . The company traded as low as $0.94 and last traded at $0.94. Approximately 2,402 shares traded hands during mid-day trading, a decline of 11% from the average daily volume of 2,709 shares. The stock had previously closed at $0.94.

Fresh Tracks Therapeutics Trading Down 0.5 %

The firm has a market capitalization of $5.58 million, a PE ratio of -0.66 and a beta of 0.54. The business’s 50 day simple moving average is $0.92 and its two-hundred day simple moving average is $0.79.

About Fresh Tracks Therapeutics

(Get Free Report)

Fresh Tracks Therapeutics, Inc does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc was founded in 2009 and is headquartered in Boulder, Colorado.

See Also

Receive News & Ratings for Fresh Tracks Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresh Tracks Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.